Efficient gene transfer and expression of biologically active glial cell line-derived neurotrophic factor in rat motoneurons transduced with lentiviral vectors

Journal of Neurochemistry

Volumn 74, Issue 5, 2000, Pages 1820-1828

  Cisterni, C ^a   Henderson, C E ^a   Aebischer, P ^b   Pettmann, B ^a,c   Deglon N ^b  

^a AIX MARSEILLE UNIVERSITÉ   (France)

^b University of Lausanne Medical Center   (Switzerland)

^c CNRS   (France)

Author keywords

Gene transfer; Glial cell line derived neurotrophic factor; Lentiviral vectors; Motoneurons; Survival; Transduction

Indexed keywords

NEUROTROPHIC FACTOR; VIRUS VECTOR;

ANIMAL CELL; ARTICLE; CONTROLLED STUDY; EMBRYO; GENE ACTIVATION; GENE EXPRESSION; GENE OVEREXPRESSION; GENE THERAPY; GENE TRANSFER; GENETIC TRANSDUCTION; GLIA CELL; LENTIVIRINAE; MOTONEURON; NERVE CELL NECROSIS; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROMOTER REGION; RAT;

ANIMALS; CELL SURVIVAL; CELLS, CULTURED; EMBRYO; GENE EXPRESSION; GENE TRANSFER TECHNIQUES; GENETIC VECTORS; GLIAL CELL LINE-DERIVED NEUROTROPHIC FACTOR; LAC OPERON; LENTIVIRUS; MOTOR NEURONS; NERVE GROWTH FACTORS; NERVE TISSUE PROTEINS; RATS;

ANIMALIA; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; LENTIVIRUS;

EID: 0034006180     PISSN: 00223042     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1471-4159.2000.0741820.x     Document Type: Article

References (53)

1. Anderson W. F. (1998) Human gene therapy. Nature 392, 25-30.
2. Arce V., Garces A., de Bovis B., Filippi P., Henderson C., Pettmann B., and deLapeyriere O. (1999) Cardiotrophin-1 requires LIFRbeta to promote survival of mouse motoneurons purified by a novel technique. J. Neurosci. Res. 55, 119-126.
3. Baumgartner B. J. and Shine H. D. (1998) Permanent rescue of lesioned neonatal motoneurons and enhanced axonal regeneration by adenovirus-mediated expression of glial cell-line-derived neurotrophic factor. J. Neurosci. Res. 54, 766-777.
4. Blömer U., Naldini L., Kafri T., Trono D., Verma I. M., and Gage F. H. (1997) Highly efficient and sustained gene transfer in adult neurons with a lentivirus vector. J. Virol. 71, 6641-6649.
5. Blömer U., Kafri T., Randolph-Moore L., Verma I. M., and Gage F. H. (1998) Bcl-xL protects adult septal cholinergic neurons from axotomized cell death. Proc. Natl. Acad. Sci. USA 95, 2603-2608.
6. Byrnes A. P., Rusby J. E., Wood M. J., and Charlton H. M. (1995) Adenovirus gene transfer causes inflammation in the brain. Neuroscience 66, 1015-1024.
7. Case S. S., Price M. A., Jordan C. T., Yu X. J., Wang L., Bauer G., Haas D. L., Xu D., Stripecke R., Naldini L., Kohn D. B., and Crooks G. M. (1999) Stable transduction of quiescent CD34(+)CD38(-) human hematopoietic cells by HIV-1-based lentiviral vectors. Proc. Natl. Acad. Sci. USA 96, 2988-2993.
8. Dai Y., Schwarz E. M., Gu D., Zhang W. W., Sarvetnick N., and Verma I. M. (1995) Cellular and humoral immune responses to adenoviral vectors containing factor IX gene: tolerization of factor IX and vector antigens allows for long-term expression. Proc. Natl. Acad. Sci. USA 92, 1401-1405.
9. Déglon N., Tseng J. L., Bensadoun J.-C., Zurn A. D., Arsenijevic Y., Pereira de Almeida L., Zufferey R., Trono D., and Aebischer P. (2000) Self-inactivating lentiviral vectors with enhanced transgene expression as potential gene transfer system in Parkinson's disease. Hum. Gene Ther. 11, 179-190.
10. Dull T., Zufferey R., Kelly M., Mandel R. J., Nguyen M., Trono D., and Naldini L. (1998) A third-generation lentivirus vector with a conditional packaging system. J. Virol. 72, 8463-8471.
11. During M. J., Naegele J. R., O'Malley K. L., and Geller A. I. (1994) Long-term behavioral recovery in parkinsonian rats by an HSV vector expressing tyrosine hydroxylase. Science 266, 1399-1403.
12. Fenjves E. S., Yao S. N., Kurachi K., and Taichman L. B. (1996) Loss of expression of a retrovirus-transduced gene in human keratinocytes. J. Invest. Dermatol. 106, 576-578.
13. Fisher K. J., Gao G. P., Weitzman M. D., DeMatteo R., Burda J. F., and Wilson J. M. (1996) Transduction with recombinant adeno-associated virus for gene therapy is limited by leading-strand synthesis. J. Virol. 70, 520-532.
14. Friedmann T. (1997) Overcoming the obstacles to gene therapy. Sci. Am. 276, 96-101.
15. Gallichan W. S., Kafri T., Krahl T., Verma I. M., and Sarvetnick N. (1998) Lentivirus-mediated transduction of islet grafts with interleukin 4 results in sustained gene expression and protection from insulitis. Hum. Gene Ther. 9, 2717-2726.
16. Garcia I., Martinou I., Tsujimoto Y., and Martinou J. C. (1992) Prevention of programmed cell death of sympathetic neurons by the bcl-2 proto-oncogene. Science 258, 302-304.
17. Gimenez y Ribotta M, Revah F., Pradier L., Loquet I., Mallet J., and Privat A. (1997) Prevention of motoneuron death by adenovirus-mediated neurotrophic factors. J. Neurosci. Res. 48, 281-285.
18. Henderson C. E., Phillips H. S., Pollock R. A., Davies A. M., Lemeulle C., Armanini M., Simmons L., Moffet B., Vandlen R. A., Simpson L. C., et al. (1994) GDNF: a potent survival factor for motoneurons present in peripheral nerve and muscle. Science 266, 1062-1064.
19. Henderson C., Bloch-Gallego E., and Camu W. (1995) Purified embryonic motoneurons, in Nerve Cell Culture: A Practical Approach (Cohen J. and Wilkin G., eds), pp. 69-81. Oxford University Press, London.
20. Ho D. Y. and Sapolsky R. M. (1997) Gene therapy for the nervous system. Sci. Am. 276, 116-120.
21. Hottinger A. F., Azzouz M., Déglon N., Aebischer P., and Zurn A. D. (1999) Complete rescue of lesioned adult facial motor neurons by lentiviral mediated expression of glial cell line derived neurotrophic factor. Soc. Neurosci. Abstr. 25, 324.
22. Ju Q., Edelstein D., Brendel M. D., Brandhorst D., Brandhorst H., Bretzel R. G., and Brownlee M. (1998) Transduction of non-dividing adult human pancreatic beta cells by an integrating lentiviral vector. Diabetologia 41, 736-739.
23. Kaech S., Kim J. B., Cariola M., and Ralston E. (1996) Improved lipid-mediated gene transfer into primary cultures of hippocampal neurons. Brain Res. Mol. Brain Res. 35, 344-348.
24. Li L., Wu W., Lin L. F., Lei M., Oppenheim R. W., and Houenou L. J. (1995) Rescue of adult mouse motoneurons from injury-induced cell death by glial cell line-derived neurotrophic factor. Proc. Natl. Acad. Sci. USA 92, 9771-9775.
25. Miyoshi H., Takahashi M., Gage F. H., and Verma I. M. (1997) Stable and efficient gene transfer into the retina using an HIV-based lentiviral vector. Prof. Natl. Acad. Sci. USA 94, 10319-10323.
26. Miyoshi H., Blömer U., Takahashi M., Gage F. H., and Verma I. M. (1998) Development of a self-inactivating lentivirus vector. J. Virol. 72, 8150-8157.
27. Morsy M. A. and Caskey C. T. (1999) Expanded-capacity adenoviral vectors - the helper-dependent vectors. Mol. Med. Today 5, 18-24.
28. Naldini L. (1998) Lentiviruses as gene transfer agents for delivery to non-dividing cells. Curr. Opin. Biotechnol. 9, 457-463.
29. Naldini L., Blömer U., Gallay P., Ory D., Mulligan R., Gage F. H., Verma I. M., and Trono D. (1996a) In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector. Science 272, 263-267.
30. Naldini L., Blömer U., Gage F. H., Trono D., and Verma I. M. (1996b) Efficient transfer, integration, and sustained long-term expression of the transgene in adult rat brains injected with a lentiviral vector. Proc. Natl. Acad Sci. USA 93, 11382-11388.
31. Naughton B. A., Dai Y., Sibanda B., Scharfmann R., San Roman J., Zeigler F., and Verma I. M. (1992) Long-term expression of a retrovirally introduced beta-galactosidase gene in rodent cells implanted in vivo using biodegradable polymer meshes. Somat. Cell. Mol. Genet. 18, 451-462.
32. Neve R. L., Howe J. R., Hong S., and Kalb R. G. (1997) Introduction of the glutamate receptor subunit 1 into motor neurons in vitro and in vivo using a recombinant herpes simplex virus. Neuroscience 79, 435-447.
33. Pakzaban P. and Chiocca E. A. (1994) Nerve growth factor protects against herpes simplex virus type 1 neurotoxicity in the rat striatum. Neuroreport 5, 993-996.
34. Palmer T. D., Rosman G. J., Osborne W. R., and Miller A. D. (1991) Genetically modified skin fibroblasts persist long after transplantation but gradually inactivate introduced genes. Proc. Natl. Acad. Sci. USA 88, 1330-1334.
35. Ramesh N., Lau S., Palmer T. D., Storb R., and Osborne W. R. (1993) High-level human adenosine deaminase expression in dog skin fibroblasts is not sustained following transplantation. Hum. Gene Ther. 4, 3-7.
36. Regulier E., Schneider B. L., Déglon N., Beuzard Y., and Aebischer P. (1998) Continuous delivery of human and mouse erythropoietin in mice by genetically engineered polymer encapsulated myoblasts. Gene Ther. 5, 1014-1022.
37. Richardson J. H., Hofmann W., Sodroski J. G., and Marasco W. A. (1998) Intrabody-mediated knockout of the high-affinity IL-2 receptor in primary human T cells using a bicistronic lentivirus vector. Gene Ther. 5, 635-644.
38. Sagot Y., Tan S. A., Hammang J. P., Aebischer P., and Kato A. C. (1996) GDNF slows loss of motoneurons but not axonal degeneration or premature death of pmn/pmn mice. J. Neurosci. 16, 2335-2341.
39. Scharfmann R., Axelrod J. H., and Verma I. M. (1991) Long-term in vivo expression of retrovirus-mediated gene transfer in mouse fibroblast implants. Proc. Natl. Acad. Sci. USA 88, 4626-4630.
40. Sonza S., Maerz A., Deacon N., Meanger J., Mills J., and Crowe S. (1996) Human immunodeficiency virus type 1 replication is blocked prior to reverse transcription and integration in freshly isolated peripheral blood monocytes. J. Virol 70, 3863-3869.
41. + T cells are infectible by human immunodeficiency virus but do not release virus after activation. J. Virol. 69, 5659-5665.
42. Tripathy S. K., Black H. B., Goldwasser E., and Leiden J. M. (1996) Immune responses to transgene-encoded proteins limit the stability of gene expression after injection of replication-defective adenovirus vectors. Nat. Med. 2, 545-550.
43. Verma I. M. and Somia N. (1997) Gene therapy - promises, problems and prospects. Nature 389, 239-242.
44. Vincent-Lacaze N., Snyder R. O., Gluzman R., Bohl D., Lagarde C., and Danos O. (1999) Structure of adeno-associated virus vector DNA following transduction of the skeletal muscle. J. Virol. 73, 1949-1955.
45. Whittle N. (1998) Gene therapy - the gutless approach pays off. Trends Genet. 14, 136-137.
46. Xu H., Federoff H., Maragos J., Parada L. F., and Kessler J. A. (1994) Viral transduction of trkA into cultured nodose and spinal motor neurons conveys NGF responsiveness. Dev. Biol. 163, 152-161.
47. Van Q., Matheson C., and Lopez O. T. (1995) In vivo neurotrophic effects of GDNF on neonatal and adult facial motor neurons. Nature 373, 341-344.
48. Yang K., Faustinella F., Xue J. J., Whitson J., Kampfl A., Mu X. S., Zhao X., Taglialatela G., Perez-Polo J. R., Clifton G., and Hayes R. L. (1994) Sustained expression of functional nerve growth factor in primary septo-hippocampal cell cultures by liposome-mediated gene transfer. Neurosci. Lett. 182, 291-294.
49. Yang Y., Nunes F. A., Berencsi K., Furth E. E., Gonczol E., and Wilson J. M. (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc. Natl. Acad. Sci. USA 91, 4407-4411.
50. Zack J. A., Arrigo S. J., Weitsman S. R., Go A. S., Haislip A., and Chen I. S. (1990) HIV-1 entry into quiescent primary lymphocytes: molecular analysis reveals a labile, latent viral structure. Cell 61, 213-222.
51. Zack J. A., Haislip A. M., Krogstad P., and Chen I. S. (1992) Incompletely reverse-transcribed human immunodeficiency virus type 1 genomes in quiescent cells can function as intermediates in the retroviral life cycle. J. Virol. 66, 1717-1725.
52. Zufferey R., Nagy D., Mandel R. J., Naldini L., and Trono D. (1997) Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo. Nat. Biotechnol. 15, 871-875.
53. Zufferey R., Dull T., Mandel R. J., Bukovsky A., Quiroz D., Naldini L., and Trono D. (1998) Self-inactivating lentivirus vector for safe and efficient in vivo gene delivery. J. Virol. 72, 9873-9880.